CNBX Pharmaceuticals Inc.
CNBX
$0.0023
$0.000315.00%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 78.56% | 80.73% | 89.44% | 15.58% | 87.60% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -100.00% | -18.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.44% | -93.32% | -91.50% | -100.00% | -93.26% |
| Change in Net Operating Assets | 230.95% | -137.50% | -115.71% | 114.08% | -96.78% |
| Cash from Operations | 58.44% | 45.54% | -335.61% | 101.08% | -572.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -19.03% |
| Total Debt Issued | -- | 20.00% | -98.00% | -91.33% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 20.00% | -98.00% | -91.33% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 163.60% | 81.04% | -154.97% | 1,108.33% | -270.50% |